Treatment options for health care–associated MRSA or community-associated MRSA pneumonia include seven to 21 days of intravenous vancomycin or linezolid, or clindamycin (600 mg orally …

In this review, we focus on the current evidence for treating MRSA infections with linezolid and discuss its pharmacologic and antimicrobial properties. In particular, recent studies on linezolid …

Objective: American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines suggest that linezolid (LZD) is preferred over vancomycin (VCM) for treating …

Vancomycin or daptomycin are the agents of choice for treatment of invasive MRSA infections [1]. Alternative agents that may be used for second-line or salvage therapy include telavancin, …

Recent studies suggesting clinical superiority of linezolid over vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) pneumonia led to a change in our …

This review concluded that linezolid appeared to be more effective than vancomycin for microbiological eradication in methicillin-resistant Staphylococcus aureus (MRSA) evaluable …

2023年4月2日 · Linezolid (LZD) affords superior tissue penetration to VCM or DAP and has been successfully used as salvage therapy for persistent MRSA bacteremia, indicating its utility as a …

2016年2月28日 · Zyvox has an average rating of 9.2 out of 10 from a total of 14 reviews for the treatment of Methicillin-Resistant Staphylococcus Aureus Infection. 100% of reviewers …

Data supporting oral step-down therapy in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) are sparse; linezolid offers potential in this setting. This study …

2010年8月19日 · Linezolid (Zyvox) is the first oxazolidinone approved for the treatment of skin and soft tissue infections, bacter-emia, and community and nosocomial pneumonia caused by …